| 21114 | Humans |
| 10619 | Male |
| 10382 | Female |
| 8620 | Animals |
| 6709 | Adult |
| 6293 | Middle Aged |
| 4621 | Aged |
| 3812 | Germany |
| 2344 | Mice |
| 2212 | Adolescent |
| 2064 | Treatment Outcome |
| 2020 | Time Factors |
| 1798 | Molecular Sequence Data |
| 1742 | Rats |
| 1505 | Aged, 80 and over |
| 1495 | Child |
| 1275 | Cells, Cultured |
| 1241 | Prospective Studies |
| 1225 | Risk Factors |
| 1194 | Amino Acid Sequence |
| 1183 | Magnetic Resonance Imaging |
| 1103 | Sensitivity and Specificity |
| 1100 | Follow-Up Studies |
| 1056 | Immunohistochemistry |
| 1033 | RNA, Messenger |
| 1022 | Mutation |
| 1007 | Retrospective Studies |
| 982 | Signal Transduction |
| 946 | Base Sequence |
| 916 | Cell Line |
| 908 | Reproducibility of Results |
| 870 | Dose-Response Relationship, Drug |
| 850 | Child, Preschool |
| 833 | Models, Molecular |
| 830 | Cell Line, Tumor |
| 804 | Reverse Transcriptase Polymerase Chain Reaction |
| 797 | Prognosis |
| 797 | Brain |
| 790 | Models, Biological |
| 750 | Risk Assessment |
| 717 | Apoptosis |
| 699 | Protein Binding |
| 686 | Polymerase Chain Reaction |
| 659 | Algorithms |
| 645 | Kinetics |
| 642 | Infant |
| 638 | Molecular Structure |
| 610 | Gene Expression Regulation |
| 608 | Cell Proliferation |
| 576 | Disease Models, Animal |
| 574 | Recombinant Proteins |
| 568 | Protein Structure, Tertiary |
| 561 | Binding Sites |
| 555 | Questionnaires |
| 552 | Computer Simulation |
| 542 | Neurons |
| 531 | Case-Control Studies |
| 529 | Tomography, X-Ray Computed |
| 529 | Rats, Wistar |
| 522 | Blotting, Western |
| 515 | Membrane Proteins |
| 506 | Image Processing, Computer-Assisted |
| 505 | Genotype |
| 503 | Biological Markers |
| 502 | Transcription Factors |
| 502 | Phenotype |
| 498 | Severity of Illness Index |
| 489 | Bacterial Proteins |
| 487 | Pregnancy |
| 484 | Phylogeny |
| 484 | Cell Differentiation |
| 484 | Analysis of Variance |
| 483 | Mice, Inbred C57BL |
| 472 | Gene Expression Profiling |
| 469 | Swine |
| 468 | Survival Analysis |
| 462 | Age Factors |
| 459 | Gene Expression |
| 457 | Infant, Newborn |
| 455 | Transfection |
| 445 | DNA |
| 442 | DNA-Binding Proteins |
| 440 | Sequence Analysis, DNA |
| 440 | Diagnosis, Differential |
| 433 | Proteins |
| 423 | Neoplasms |
| 419 | Models, Chemical |
| 417 | Promoter Regions, Genetic |
| 416 | Postoperative Complications |
| 415 | Incidence |
| 410 | Transcription, Genetic |
| 410 | Protein Conformation |
| 406 | Temperature |
| 403 | Phosphorylation |
| 402 | Oligonucleotide Array Sequence Analysis |
| 400 | Sequence Alignment |
| 400 | DNA Primers |
| 395 | Antineoplastic Agents |
| 392 | Liver |
| 389 | Cytokines |
| 389 | Cattle |
| 388 | Oxygen |
| 384 | Flow Cytometry |
| 382 | Hydrogen-Ion Concentration |
| 380 | Escherichia coli |
| 375 | Calcium |
| 373 | History, 20th Century |
| 364 | Predictive Value of Tests |
| 363 | Prevalence |
| 361 | Sequence Homology, Amino Acid |
| 360 | Cohort Studies |
| 359 | Peptides |
| 359 | Brain Mapping |
| 357 | Ligands |
| 356 | Breast Neoplasms |
| 354 | Recurrence |
| 354 | Mice, Knockout |
| 354 | Magnetic Resonance Spectroscopy |
| 354 | Chronic Disease |
| 353 | Enzyme-Linked Immunosorbent Assay |
| 352 | Rats, Sprague-Dawley |
| 352 | Chromatography, High Pressure Liquid |
| 350 | Clinical Trials as Topic |
| 346 | Up-Regulation |
| 346 | Species Specificity |
| 344 | Reference Values |
| 344 | Disease Progression |
| 341 | Oxidation-Reduction |
| 340 | Enzyme Inhibitors |
| 338 | Polymorphism, Genetic |
| 338 | Europe |
| 338 | Cross-Sectional Studies |
| 337 | Statistics, Nonparametric |
| 331 | Equipment Design |
| 329 | Tumor Necrosis Factor-alpha |
| 329 | T-Lymphocytes |
| 328 | Reaction Time |
| 328 | Cell Membrane |
| 326 | Practice Guidelines as Topic |
| 323 | Crystallography, X-Ray |
| 321 | Membrane Glycoproteins |
| 321 | Cloning, Molecular |
| 320 | Survival Rate |
| 320 | Anti-Bacterial Agents |
| 319 | Water |
| 319 | Software |
| 319 | Quality of Life |
| 313 | Sex Factors |
| 313 | Neoplasm Staging |
| 313 | Cell Survival |
| 311 | Antibodies, Monoclonal |
| 308 | Imaging, Three-Dimensional |
| 303 | Recombinant Fusion Proteins |
| 300 | Combined Modality Therapy |
| 296 | Electroencephalography |
| 295 | Mass Spectrometry |
| 289 | Endothelium, Vascular |
| 288 | Blood Pressure |
| 286 | Microscopy, Fluorescence |
| 285 | Kidney |
| 285 | Double-Blind Method |
| 283 | Antineoplastic Combined Chemotherapy Protocols |
| 283 | Acute Disease |
| 279 | Green Fluorescent Proteins |
| 278 | Models, Statistical |
| 277 | Surface Properties |
| 277 | Aging |
| 276 | Immunosuppressive Agents |
| 276 | Comorbidity |
| 275 | Genetic Predisposition to Disease |
| 275 | Gene Expression Regulation, Neoplastic |
| 274 | Functional Laterality |
| 274 | Contrast Media |
| 272 | Tumor Markers, Biological |
| 270 | DNA Mutational Analysis |
| 269 | Fibroblasts |
| 267 | Cell Nucleus |
| 266 | Structure-Activity Relationship |
| 265 | Nerve Tissue Proteins |
| 264 | Nuclear Proteins |
| 262 | Carrier Proteins |
| 261 | Enzyme Activation |
| 260 | Cell Movement |
| 258 | Mice, Transgenic |
| 256 | Inflammation |
| 256 | DNA, Complementary |
| 255 | Muscle, Skeletal |
| 255 | Down-Regulation |
| 253 | Photic Stimulation |
| 252 | Physician's Practice Patterns |
| 251 | Endothelial Cells |
| 249 | Skin |
| 248 | Genetic Variation |
| 246 | Substrate Specificity |
| 246 | Catalysis |
| 245 | Models, Theoretical |
| 240 | Drug Therapy, Combination |
| 239 | Mice, Inbred BALB C |
| 237 | Pilot Projects |
| 236 | Quality Assurance, Health Care |
| 235 | Microscopy, Confocal |
| 235 | Cell Adhesion |
| 234 | Plasmids |
| 233 | Cerebral Cortex |
| 232 | Protein Transport |
| 231 | Stents |
| 231 | DNA, Bacterial |
| 229 | Models, Genetic |
| 228 | Gene Expression Regulation, Developmental |
| 227 | Neuropsychological Tests |
| 226 | Peptide Fragments |
| 226 | Environmental Monitoring |
| 226 | Electrocardiography |
| 224 | History, 19th Century |
| 223 | Psychomotor Performance |
| 223 | Feasibility Studies |
| 222 | Tumor Cells, Cultured |
| 222 | Evolution, Molecular |
| 221 | Materials Testing |
| 220 | In Situ Hybridization, Fluorescence |
| 220 | HeLa Cells |
| 219 | Stereoisomerism |
| 219 | Genetic Vectors |
| 219 | Alleles |
| 218 | Thermodynamics |
| 218 | Lung |
| 217 | Positron-Emission Tomography |
| 217 | National Health Programs |
| 217 | Bacteria |
| 215 | Hippocampus |
| 214 | Mitochondria |
| 213 | Plant Proteins |
| 213 | Myocardial Infarction |
| 212 | Molecular Conformation |
| 211 | Polymorphism, Single Nucleotide |
| 207 | Epithelial Cells |
| 207 | Attention |
| 206 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
| 206 | Lymphocyte Activation |
| 206 | Chromosome Mapping |
| 206 | Antigens, CD |
| 204 | Biological Transport |
| 203 | Light |
| 202 | Liver Neoplasms |
| 200 | Stem Cells |
| 200 | Electrophoresis, Polyacrylamide Gel |
| 200 | Computational Biology |
| 198 | Animals, Newborn |
| 197 | United States |
| 196 | Receptors, Cell Surface |
| 196 | Data Interpretation, Statistical |
| 196 | Cardiovascular Diseases |
| 195 | Trans-Activators |
| 194 | Saccharomyces cerevisiae |
| 194 | Protein-Serine-Threonine Kinases |
| 194 | Prostatic Neoplasms |
| 194 | Nitric Oxide |
| 194 | Cell Division |
| 194 | Adenocarcinoma |
| 193 | Insulin |
| 193 | Drug Administration Schedule |
| 193 | Administration, Oral |
| 192 | Neoplasm Proteins |
| 192 | Dogs |
| 191 | Gene Frequency |
| 190 | Rabbits |
| 190 | Neoplasm Recurrence, Local |
| 190 | Membrane Potentials |
| 190 | Electric Stimulation |
| 189 | Dendritic Cells |
| 189 | Brain Neoplasms |
| 188 | Particle Size |
| 188 | Cricetinae |
| 188 | Arabidopsis |
| 187 | Plant Leaves |
| 186 | Patch-Clamp Techniques |
| 186 | Macrophages |
| 185 | Myocardium |
| 185 | Lung Neoplasms |
| 185 | Image Enhancement |
| 185 | Dimerization |
| 185 | Biopsy |
| 184 | RNA |
| 183 | Schizophrenia |
| 183 | Oxidative Stress |
| 182 | Regression Analysis |
| 182 | In Situ Hybridization |
| 182 | Disease-Free Survival |
| 181 | Stroke |
| 180 | Heart Rate |
| 180 | Fluorescent Dyes |
| 180 | Diabetes Mellitus, Type 2 |
| 179 | Hemodynamics |
| 179 | Carcinoma, Squamous Cell |
| 178 | Tissue Distribution |
| 177 | Protein Structure, Secondary |
| 177 | Cell Culture Techniques |
| 176 | Body Mass Index |
| 175 | Exons |
| 174 | Randomized Controlled Trials as Topic |
| 173 | Transforming Growth Factor beta |
| 173 | Spectrometry, Fluorescence |
| 173 | Multivariate Analysis |
| 172 | Protein Isoforms |
| 172 | Hypertension |
| 171 | Spectrometry, Mass, Electrospray Ionization |
| 171 | Polymers |
| 171 | Biomechanical Phenomena |
| 169 | Saccharomyces cerevisiae Proteins |
| 169 | Models, Animal |
| 168 | Radiopharmaceuticals |
| 167 | Proto-Oncogene Proteins |
| 167 | Microscopy, Electron, Scanning |
| 167 | Heart Failure |
| 166 | Caspases |
| 165 | User-Computer Interface |
| 165 | Colorectal Neoplasms |
| 163 | Ultraviolet Rays |
| 163 | Solubility |
| 163 | Protein Folding |
| 163 | Pain Measurement |
| 163 | Lipids |
| 163 | Image Interpretation, Computer-Assisted |
| 163 | Forecasting |
| 163 | Electrophysiology |
| 163 | Actins |
| 162 | Glucose |
| 161 | Movement |
| 161 | Monocytes |
| 160 | Pain |
| 160 | Immunoglobulin G |
| 160 | Gene Deletion |
| 160 | Coronary Angiography |
| 159 | Stress, Mechanical |
| 159 | Psychiatric Status Rating Scales |
| 159 | Equipment Failure Analysis |
| 158 | Mutagenesis, Site-Directed |
| 158 | Crystallization |
| 158 | Cell Count |
| 158 | Alzheimer Disease |
| 158 | Acoustic Stimulation |
| 157 | Reoperation |
| 157 | Gene Expression Regulation, Bacterial |
| 156 | Statistics as Topic |
| 156 | Interleukin-6 |
| 155 | Visual Perception |
| 155 | Obesity |
| 155 | Kidney Transplantation |
| 154 | Gene Expression Regulation, Plant |
| 153 | Mental Disorders |
| 152 | Longitudinal Studies |
| 152 | Interferon-gamma |
| 152 | Drug Interactions |
| 152 | Cell Cycle Proteins |
| 152 | Body Weight |
| 151 | Melanoma |
| 150 | Gas Chromatography-Mass Spectrometry |
| 150 | Cell Cycle |
| 150 | Adenosine Triphosphate |
| 149 | Skin Neoplasms |
| 149 | Coronary Disease |
| 149 | Adaptation, Physiological |
| 148 | Behavior, Animal |
| 147 | Smoking |
| 147 | Neoplasm Metastasis |
| 146 | Escherichia coli Proteins |
| 146 | B-Lymphocytes |
| 146 | Amino Acids |
| 145 | Outcome Assessment (Health Care) |
| 145 | Neoplasm Invasiveness |
| 144 | Plant Extracts |
| 143 | Reactive Oxygen Species |
| 143 | Lipopolysaccharides |
| 143 | Culture Media |
| 143 | Arthritis, Rheumatoid |
| 143 | Amino Acid Substitution |
| 142 | Repressor Proteins |
| 142 | Protein Subunits |
| 142 | Pancreatic Neoplasms |
| 142 | Haplotypes |
| 142 | Glycoproteins |
| 142 | Genetic Markers |
| 142 | Cercopithecus aethiops |
| 141 | Plant Roots |
| 141 | Lasers |
| 141 | Dose-Response Relationship, Radiation |
| 140 | Microscopy, Electron |
| 140 | Lymphatic Metastasis |
| 140 | Coronary Artery Disease |
| 140 | Collagen |
| 140 | Cognition |
| 139 | Retina |
| 138 | Water Pollutants, Chemical |
| 138 | Proteome |
| 138 | Membrane Transport Proteins |
| 138 | Gene Expression Regulation, Enzymologic |
| 138 | Cytoplasm |
| 138 | Action Potentials |
| 137 | Microscopy, Electron, Transmission |
| 137 | Microbial Sensitivity Tests |
| 136 | Registries |
| 136 | Pedigree |
| 136 | Patient Satisfaction |
| 136 | Intracellular Signaling Peptides and Proteins |
| 136 | Genes, Reporter |
| 136 | DNA Damage |
| 136 | Cross-Over Studies |
| 135 | Proteomics |
| 135 | Hot Temperature |
| 135 | Blood Glucose |
| 134 | RNA, Small Interfering |
| 134 | RNA Interference |
| 134 | Nucleic Acid Hybridization |
| 134 | Kidney Failure, Chronic |
| 134 | Iron |
| 134 | Glucocorticoids |
| 134 | Biological Evolution |
| 133 | Psychometrics |
| 133 | Evidence-Based Medicine |
| 133 | Adsorption |
| 132 | NF-kappa B |
| 132 | Molecular Weight |
| 132 | Models, Neurological |
| 132 | Biocompatible Materials |
| 131 | Lymphocytes |
| 131 | Blood Platelets |
| 131 | Antibodies |
| 130 | Organometallic Compounds |
| 130 | Memory |
| 130 | Fluorescent Antibody Technique |
| 130 | Ecosystem |
| 129 | Multigene Family |
| 129 | CD4-Positive T-Lymphocytes |
| 129 | Age Distribution |
| 128 | HIV Infections |
| 127 | Vascular Endothelial Growth Factor A |
| 127 | Random Allocation |
| 127 | Cost-Benefit Analysis |
| 127 | COS Cells |
| 127 | Biophysics |
| 126 | Logistic Models |
| 126 | Laparoscopy |
| 126 | Internet |
| 126 | Graft Rejection |
| 125 | Liver Transplantation |
| 125 | Heart |
| 125 | Conserved Sequence |
| 125 | Cluster Analysis |
| 125 | Anticoagulants |
| 124 | Leukocytes |
| 124 | Hepatocytes |
| 124 | Cognition Disorders |
| 124 | Chi-Square Distribution |
| 124 | Antioxidants |
| 123 | Population Surveillance |
| 123 | Isoenzymes |
| 123 | Evoked Potentials |
| 123 | Data Collection |
| 123 | Circadian Rhythm |
| 123 | Carbon |
| 123 | Carbon Dioxide |
| 122 | RNA, Ribosomal, 16S |
| 122 | Probability |
| 122 | Nitric Oxide Synthase |
| 122 | Nanostructures |
| 122 | Electrophoresis, Gel, Two-Dimensional |
| 122 | Anti-Inflammatory Agents |
| 121 | Virus Replication |
| 121 | Transplantation, Homologous |
| 121 | RNA, Viral |
| 121 | Hydrocortisone |
| 120 | Recovery of Function |
| 120 | Nucleic Acid Conformation |
| 120 | Cerebrovascular Circulation |
| 119 | Nerve Net |
| 119 | Nanotechnology |
| 119 | Feces |
| 118 | Oocytes |
| 118 | Disability Evaluation |
| 118 | DNA, Viral |
| 118 | Chromosome Aberrations |
| 118 | Blotting, Northern |
| 118 | Biodegradation, Environmental |
| 117 | Tyrosine |
| 117 | Sex Distribution |
| 117 | Phantoms, Imaging |
| 117 | Magnetic Resonance Angiography |
| 117 | Ion Channels |
| 117 | Immunoblotting |
| 117 | Drug Delivery Systems |
| 117 | Drosophila Proteins |
| 117 | CD8-Positive T-Lymphocytes |
| 116 | Radiation Dosage |
| 116 | Pyrimidines |
| 116 | Point Mutation |
| 116 | Observer Variation |
| 116 | Motor Activity |
| 116 | Cholesterol |
| 115 | Stress, Psychological |
| 115 | Risk |
